Welcome

Celebrating Over 75 Years Of Service

The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.

"Dedicated to enhancing knowledge and skill in the care of the allergic patient."

ADVOCACY UPDATES

What you need to comply with the pending USP General Chapter <797> Pharmaceutical Compounding — Sterile Preparations

3 key compliance criteria While the implementation date of the new USP General Chapter <797>…

read more

2019 AAOA Advanced Course in Allergy & immunology Optional USP 797 Compliance Workshop

Cost: $125 for AAOA members and $300 for non-members* in addition to AAOA Advanced Course registration…

read more

NEWS! USP General Chapter <797> Implementation Postponed

The United States Pharmacopeia announced that, due to appeals underway, the previously announced implementation date…

read more

Changes in MACRA

Macra 101 Image

Before the close of 2017, all physicians must take action to avoid the 4 percent cut that will be assessed in 2019 for not participating in the new Quality Payment Program (QPP) authorized by the Medicare Access and CHIP Reauthorization Act (MACRA).  Read More

CMS Announces Changes in MACRA Implementation Timeline. The Centers for Medicare and Medicaid Services (CMS) announced major changes to the implementation of the Medicare Access and CHIP Re-authorization (MACRA).
Read More

Upcoming Dates

12/01/19: Research Grant Cycle
Learn more

02/15/20: Crowdsourcing for 2020 Scottsdale
Learn more

02/15/20: Call for Proposals
Learn more

04/01/20: Fellow Exam Application Deadline
Learn more

06/01/20: Research Grant Cycle
Learn more

06/26/20: Membership Application Deadline to be eligible for AAOA Member rate for the 2020 Basic Course Learn more

09/11/20: Membership Application Deadline to be voted in at the 2020 Annual Meeting and to be eligible for AAOA Member Rate (FREE) for the 2020 Annual Meeting Learn more

EDUCATION

Here is What You Missed...

2019 New Orleans was an outstanding success?  With over 500 participants, our AAOA members left New Orleans re-energized, re-freshed, and re-engaged.  The program offered something for everyone — from cutting edge clinical content to every day how to’s for practice management efficiencies. Read More

AAOA in the Lone Star

Join us in the Lone Star State for the 2019 AAOA Advanced Course in Allergy and Immunology. This course builds on the basic clinical care of allergic patient concepts and techniques presented at the AAOA’s Basic Course in Allergy & Immunology. Read More

IFAR

IFAR Impact Factor: 2.454

aaoaf-ifar

Now Available

Changes in Managing Practices

Mission

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices.

Read More

Live and Online CME

2019 Advanced Course in Allergy & Immunology
December 12-14 | Austin, TX
Learn More and Register

2020 Basic Course in Allergy & Immunology
July 9-11 | Orlando, FL
Save the Date

2020 AAOA Annual Meeting
October 23-25| Scottsdale, AZ
Save the Date

AAOA Clinical Insights
Learn More and Register

PATIENT CORNER

Off to College: Tips for Managing Allergies

Heading to college is an exciting time. What are the best ways for students to avoid exacerbation of their symptoms as they enter the hallowed halls of higher learning?

Read More

College Allergy Symptoms Treatment Back to Shcool

News and Updates

Should I Go to Austin?

We get it.  You’ve been to the Advanced Course on Allergy & Immunology, so you…

read more

CEO September 2019 Update

by Jami Lucas, AAOA CEO/Executive Director Over 500 AAOA members were engaged, learning, and networking…

read more

Here is What You Missed…

2019 New Orleans was an outstanding success?  With over 500 participants, our AAOA members left…

read more

Menu

Practice Resources

Ingestion Challenge Testing

peanuts-2163043_640

Ingestion Challenge Testing Update 2013

Previously ingestion challenge testing for food, drugs or other substance was reported under Code 95075. That code has been deleted and effective January 1, 2013 is replaced by two new codes 95076 and 95079.

Code 95076 is defined as Ingestion challenge test (sequential and incremental ingestion of test items, e.g., food, drug or other substance); initial 120 minutes of testing.

Code 95079 is an add on code always reported with Code 95076 and is defined as each additional minutes of testing (list separately in addition to code for primary procedure.

As an example for the use of the new codes for drug allergy testing, consider a common protocol for penicillin allergy testing.  An initial single prick test is performed with each of the following: histamine, saline, benzylpenicilloyl polylysine (Pre-Pen), and penicillin G.

If these tests are “negative”, intradermal tests are then performed in the following manner: one intradermal application of a saline control, and two intradermal injections each for benzylpenicilloyl polylysine and penicillin G.

If the intradermal tests are “negative”, then on oral challenge with a penicillin product is given, and the patient is observed for one hour. The physician should bill for 9 units of 95018 (4 prick and 5 intradermal tests), and 1 unit of 95076 for the oral challenge test.

A Member Benefit

Allergy and Rhinology Journal (IFAR)

The International Forum of Allergy & Rhinology (IFAR) is the official journal of the AAOA and the American Rhinologic Society (ARS). Published monthly by John Wiley & Sons, Inc., IFAR provides a forum for clinical researchers, basic scientists, clinicians, and others to publish original research and explore controversies in the medical and surgical treatment of patients with otolaryngic allergy, rhinologic, and skull base conditions.

President Mims Message

April 2017

Working together with AAOA staff, volunteer leadership and members will enable us to have a positive impact on our members’ practices. Read More

News

New Articles from IFAR

Safety of long-term Intranasal Budesonide

The aim of this study was to determine the impact of long-term topical budesonide treatment via the mucosal atomization device (MAD) on the hypothalamic-pituitary-adrenal axis (HPAA) and intraocular pressure (IOP).. Read More

Medical therapy for Chronic Rhino-sinusitis

The indications for surgical management of chronic rhinosinusitis (CRS) in patients with cystic fibrosis (CF) are poorly defined..
Read More

New Blog Posts

Posts from AAOA Leaders

Allergies, not just for summer anymore. Read More

How to treat allergies at home.
Read More